HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles W Emala Selected Research

rapacuronium (Raplon)

12/2005Rapacuronium augments acetylcholine-induced bronchoconstriction via positive allosteric interactions at the M3 muscarinic receptor.
1/2005Rapacuronium preferentially antagonizes the function of M2 versus M3 muscarinic receptors in guinea pig airway smooth muscle.
4/2003A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles W Emala Research Topics

Disease

30Asthma (Bronchial Asthma)
10/2022 - 03/2002
19Inflammation (Inflammations)
01/2022 - 01/2004
12Reperfusion Injury
02/2008 - 01/2002
10Ischemia
12/2007 - 02/2001
8Respiratory Hypersensitivity
02/2022 - 03/2002
8Bronchial Spasm
12/2020 - 04/2003
7Necrosis
02/2008 - 01/2004
5Pneumonia (Pneumonitis)
02/2022 - 01/2020
5Brain Neoplasms (Brain Tumor)
12/2017 - 04/2007
4Peritonitis
04/2007 - 10/2004
4Sepsis (Septicemia)
04/2007 - 10/2004
3Neoplasms (Cancer)
12/2017 - 12/2016
3Glioma (Gliomas)
01/2017 - 01/2016
3Chronic Obstructive Pulmonary Disease (COPD)
09/2013 - 06/2008
2Infections
01/2020 - 03/2003
2Obesity
11/2019 - 06/2005
2Cough
01/2017 - 01/2017
2Anaphylaxis (Anaphylactic Shock)
06/2010 - 11/2009
2Renal Insufficiency (Renal Failure)
12/2007 - 02/2003
2Hypersensitivity (Allergy)
12/2005 - 03/2002
1Airway Remodeling
11/2021
1Respiratory Insufficiency (Respiratory Failure)
12/2020
1Cystic Fibrosis (Mucoviscidosis)
01/2020
1Mucoepidermoid Carcinoma
01/2018

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
10/2022 - 05/2014
8Anesthetics (Anesthetic Agents)IBA
01/2013 - 12/2004
8Purinergic P1 Receptors (Adenosine Receptor)IBA
12/2007 - 01/2002
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007 - 03/2003
5OvalbuminIBA
12/2020 - 12/2013
5Methacholine Chloride (Methacholine)FDA Link
12/2020 - 02/2001
5IsofluraneFDA LinkGeneric
01/2013 - 12/2004
5CreatinineIBA
10/2006 - 01/2004
4MIDD0301IBA
01/2022 - 01/2018
4Proteins (Proteins, Gene)FDA Link
09/2020 - 10/2004
4CytokinesIBA
09/2020 - 03/2003
4LigandsIBA
01/2018 - 01/2012
4Messenger RNA (mRNA)IBA
01/2013 - 02/2004
3LipopolysaccharidesIBA
02/2022 - 12/2020
3shogaolIBA
01/2020 - 02/2013
3Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2013 - 12/2005
3Sevoflurane (Ultane)FDA LinkGeneric
02/2008 - 12/2004
3Pentobarbital (Nembutal)FDA Link
09/2007 - 12/2004
3rapacuronium (Raplon)FDA Link
12/2005 - 04/2003
2SteroidsIBA
02/2022 - 12/2020
2Albuterol (Salbutamol)FDA LinkGeneric
02/2022 - 12/2020
2AntigensIBA
09/2020 - 01/2020
2Volatile Fatty AcidsIBA
01/2020 - 11/2019
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2017 - 12/2013
2MicellesIBA
01/2017 - 01/2016
2gingerolIBA
01/2014 - 02/2013
2LeptinIBA
01/2013 - 06/2005
2GABA-A Receptors (GABA(A) Receptor)IBA
01/2012 - 12/2008
2gamma-Aminobutyric Acid (GABA)IBA
04/2009 - 06/2008
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
02/2008 - 01/2007
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2008 - 01/2007
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2007 - 04/2007
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2006 - 08/2005
2Alanine Transaminase (SGPT)IBA
10/2006 - 08/2005
2N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
10/2006 - 02/2003
2ChemokinesIBA
10/2006 - 08/2005
2Neuromuscular Blocking AgentsIBA
12/2005 - 04/2003
2Adrenergic Agents (Adrenergic Drugs)IBA
06/2005 - 06/2002
2Adenosine Triphosphate (ATP)IBA
12/2004 - 02/2001
2Local AnestheticsIBA
10/2004 - 01/2004
2Peroxidase (Myeloperoxidase)IBA
10/2004 - 02/2004
21,3-dipropyl-8-cyclopentylxanthineIBA
02/2004 - 01/2004
1InterferonsIBA
01/2022
1MelatoninIBA
12/2021
1AllergensIBA
12/2020
1Fluticasone (Cutivate)FDA LinkGeneric
12/2020
1Interferon-gamma (Interferon, gamma)IBA
12/2020
1SphingolipidsIBA
11/2020
1Chemotactic FactorsIBA
09/2020
1GelsolinIBA
09/2020
1(3,4,5- trimethoxy- N- (2- methoxyethyl)- N- (4- phenyl- 2- thiazolyl)benzamideIBA
01/2020
1ginger extractIBA
01/2020
1Acetates (Acetic Acid Esters)FDA Link
01/2020
1BenzbromaroneIBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020
1Butyrates (Butyrate)IBA
01/2020
1PropionatesIBA
01/2020
1Nonesterified Fatty Acids (NEFA)IBA
11/2019
1AdipokinesIBA
11/2019
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
01/2018
1Fluorescein (Funduscein)FDA LinkGeneric
12/2017
1Cell-Penetrating PeptidesIBA
12/2017
1Trans-Activators (Trans-Acting Factor)IBA
12/2017
1IsotopesIBA
01/2017
1DexmedetomidineFDA Link
01/2017
1Irritants (Vesicants)IBA
01/2017
1CationsIBA
01/2017
1Peptides (Polypeptides)IBA
01/2017

Therapy/Procedure

13Therapeutics
11/2021 - 07/2006
6Anesthesia
01/2013 - 12/2004
3Punctures
04/2007 - 10/2004
3Ligation
04/2007 - 10/2004
2Oral Administration
01/2022 - 01/2018
2Injections
12/2017 - 12/2004
2Drug Therapy (Chemotherapy)
12/2017 - 04/2007
2Intra-Arterial Injections
01/2017 - 01/2016